IVUS + NIRS: The PROSPECT II Study Published on The Lancet

11 March 2021

The PROSPECT II Study has been published in the current issue of The Lancet.

 

Study findings show that combined #NIRS and #IVUS detects angiographically non-obstructive lesions with a high lipid content and large plaque burden that are at increased risk for future adverse cardiac outcomes.

 

Click  The PROSPECT II Study to read more

 

Latest News:

EUKON Leader della Crescita 2022

Leader della Crescita is  rank of first 450 companies, done…

Read More >

Next Generation PCI - Symposia at GISE 42, Milan 7th Oct 2021

EUKON and SMT present Next Generation PCI Symposia at GISE…

Read More >

Expanding your frontiers in Structural Interventions - Symposia at GISE 42, Milan 7th Oct 2021

EUKON SMT present Innovations in Structural Heart Intervention PFO and TAVI…

Read More >